OBJECTIVE: Lactoferrin is an iron-binding protein that has been used f
or distinguishing normal from neoplastic conditions in many different
tissues. In order to improve evaluation of thyroid lesions, we studied
tile lactoferrin immunoreaction in cytologic smears obtained by fine
needle aspiration and in biopsy samples from primary neoplasms and fro
m adenomatous goiter. STUDY DESIGN: A retrospective study on Foe needl
e aspiration cytology samples and corresponding available biopsies fro
m thyroid lesions in patients examined at Sao Paulo County Hospital be
tween 1982 and 1992, performed in order to evaluate lactoferrin immuno
reactivity in morphologically well characterized samples from neoplast
ic and nonneoplastic lesions. Immunoperoxidase procedures were perform
ed using monospecific polyclonal rabbit antihuman lactoferrin as a pri
mary antibody and biotinylated goat antirabbit IgG as a secondary anti
body. Amplification was performed with the avidin-biotin-peroxidase co
mplex, and the color sign of the positive reactions was developed usin
g a diaminobenzidine solution. RESULTS: Lactoferrin was not detected i
vr cytologic smears from goiters, whereas only oi-le biopsy rc,ns slig
htly positive (1/21, or 4.76%). One smear front adenoma showed low pos
itive staining (1/19, or 5.26%), which was The observation that lactof
errin present in 4 of 13 biopsies (30.77%) from adenoma. Papillary car
cinomas were positive in 19 of 33 smears (57.58%) and in 100% of biops
ies, whereas 31.25% (5/16) of follicular carcinoma smears were positiv
e for lactoferrin, detected in all the biopsy samples. CONCLUSION: Lac
toferrin immunoreactivity tons strongly associated with neoplastic pro
liferation and may be used as a useful auxillary marker to distinguish
malignant from benign thyroid lesions lit cytologic smears and biopsy
samples.